Nicholas Cross


Nicholas Cross is a serial entrepreneur and hands-on investor, and joined the Aigenpulse board as Chairman in January 2018. His previous ventures have included Adaptimmune, floated on Nasdaq in 2017 where he was a co-founder and Chairman for the first five years, at Immunocore where he had an identical role, Oxford Asymmetry Ltd (now part of Evotec), Oxford Semiconductor Ltd (now part of Toshiba) in both of which he was also a co-founder and first Chairman, (now part of M3 Corporation), Oxxon (now part of Oxford Biomedica), Lansdown Estates Group Ltd (now MEPC Milton Park Ltd.), and Oxagen Ltd. Mr Cross holds a law degree from the University of Oxford and an MBA from London Business School.